These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4367141)

  • 1. Development of host-mediated mutagenicity tests. I. Differential response of yeast cells injected into testes of rats and peritoneum of mice and rats to mutagens.
    Fahrig R
    Mutat Res; 1974 Feb; 26(1):29-36. PubMed ID: 4367141
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the genetic activity of dimethylnitrosamine, ethyl methanesulfonate, 2-acetylaminofluorene and ICR-170 in Saccharomyces cerevisiae strains D3, D4 and D5 using in vitro assays with and without metabolic activation.
    Brusick D; Andrews H
    Mutat Res; 1974 Dec; 26(6):491-500. PubMed ID: 4372528
    [No Abstract]   [Full Text] [Related]  

  • 3. Triazenes, a new group of indirect mutagens. Comparative investigations of the genetic effects of different Aryldialkyltriazenes using Saccharomyces cerevisiae, the host-mediated assay, Drosophila melanogaster, and human chromosomes in vitro.
    Vogel E; Fahrig R; Obe G
    Mutat Res; 1973 Jun; 21(3):123-36. PubMed ID: 4200709
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of host-mediated mutagenicity tests-yeast systems. II. Recovery of yeast cells out of testes, liver, lung, and peritoneum of rats.
    Fahrig R
    Mutat Res; 1975 Dec; 31(6):381-94. PubMed ID: 768756
    [No Abstract]   [Full Text] [Related]  

  • 5. The advantages of drosophila for mutation studies.
    Sobels FH
    Mutat Res; 1974 Aug; 26(4):277-84. PubMed ID: 4369264
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic activation of mutagens in mammals host-mediated assay utilizing the induction of mitotic gene conversion in Saccharomyces cerevisiae.
    Fahrig R
    Agents Actions; 1973 Jun; 3(2):99-110. PubMed ID: 4580186
    [No Abstract]   [Full Text] [Related]  

  • 7. New developments in mutagenicity screening techniques with yeast.
    Brusick DJ; Mayer VW
    Environ Health Perspect; 1973 Dec; 6():83-96. PubMed ID: 4360726
    [No Abstract]   [Full Text] [Related]  

  • 8. A new method for testing genetically active metabolites. Urinary assay with cyclophosphamide (endoxan, cytoxan) and Saccharomyces cerevisiae.
    Siebert D
    Mutat Res; 1973 Mar; 17(3):307-14. PubMed ID: 4569494
    [No Abstract]   [Full Text] [Related]  

  • 9. The organospecific activity of six N-nitroso compounds in the host-mediated assay with yeast and rats.
    Fahrig R; Remmer H
    Teratog Carcinog Mutagen; 1983; 3(1):41-9. PubMed ID: 6132456
    [No Abstract]   [Full Text] [Related]  

  • 10. Aneuploidy induced by cyclophosphamide in developing rat testes.
    Saxena AK; Singh G
    In Vitro Cell Dev Biol Anim; 1998 Jan; 34(1):11-3. PubMed ID: 9542625
    [No Abstract]   [Full Text] [Related]  

  • 11. Division delay and DNA degradation after mutagen treatment of the yeast, Saccharomyces cerevisiae.
    Wilmore PJ; Parry JM
    Mol Gen Genet; 1976 Jun; 145(3):287-91. PubMed ID: 181669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pH on hycanthone methanesulfonate-induced inactivation and mitotic recombination in saccharomyces.
    Shahin MM; de Serres FJ
    Mutat Res; 1974 Oct; 26(5):377-84. PubMed ID: 4370451
    [No Abstract]   [Full Text] [Related]  

  • 13. Host-mediated assay with yeast and rats using probenecid (Benemid) to block the renal tubular excretion of cyclophosphamide metabolites.
    Siebert D
    Mutat Res; 1975 Apr; 28(1):57-61. PubMed ID: 1095921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
    Pavlov IuI; Khromov-Borisov NN
    Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation and recombination experiments with yeast as prescreening tests for carcinogenic effects?
    Marquardt H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 81(3-4):333-46. PubMed ID: 4279525
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutagenicity of dimethylnitrosamine and ethyl methanesulfonate as determined by the host-mediated CHO/HGPRT assay.
    Hsie AW; Machanoff R; Couch DB; Holland JM
    Mutat Res; 1978 Jul; 51(1):77-84. PubMed ID: 209324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of forward gene mutation and gene conversion in yeasts by treatment with cyclophosphamide in vitro and in vivo.
    Barale R; Rusciano D; Stretti G; Zucconi D; Monaco M; Mosesso P; Principe P
    Mutat Res; 1983 Nov; 111(3):295-312. PubMed ID: 6358878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of different test systems with yeasts for the evaluation of chemically induced gene conversions and gene mutations.
    Loprieno N; Barale R; Bauer C; Baroncelli S; Bronzetti G; Cammellini A; Cinci A; Corsi G; Leporini C; Nieri R; Nozzolini M; Serra C
    Mutat Res; 1974 Nov; 25(2):197-217. PubMed ID: 4372527
    [No Abstract]   [Full Text] [Related]  

  • 19. The detection of chemical mutagens using the L5178y-Asn-murine leukemia in vitro and in a host-mediated assay.
    Capizzi RL; Papirmeister B; Mullins JM; Cheng E
    Cancer Res; 1974 Nov; 34(11):3073-82. PubMed ID: 4370835
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagenic action of hycanthone and IA-4 on yeast.
    Meadows MG; Quah SK; von Borstel RC
    J Pharmacol Exp Ther; 1973 Nov; 187(2):444-50. PubMed ID: 4356017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.